Consensus Wendel

Equities

MF

FR0000121204

Market Closed - Euronext Paris Other stock markets 11:35:59 2024-04-19 am EDT			5-day change	1st Jan Change
94.1 ^EUR	+0.05%		+1.35%	+16.68%

Apr. 09	CAC40: closes in the red before ECB and US inflation announcements	CF
Apr. 09	WENDEL : Berenberg raises its price target	CF

Evolution of the average Target Price on Wendel

Price target over the last 5 years

History of analyst recommendation changes

de8ffe533e04.y1ZMcV_3NrcP-tnm0YeJ1gZB6Wz4bUxt-Vf9rLHvO9E.ohsuAQvPBdZin7GC6eXTmHQWmC6yGQ4Mlg6tyuWMYZisGj0VHrxehkTImA~4aca9988a8f840c7fe83610376df9cbb

Analyst Recommendations on Wendel

WENDEL : Berenberg raises its price target	Apr. 09	CF
Wendel: share price rises, Berenberg praises strategy	Apr. 09	CF
WENDEL : The end of Wendel's historic ties with Bureau Veritas?	Apr. 05
WENDEL : Wendel cherishes its shareholders	Feb. 29
WENDEL : Half-hearted 2023 results, albeit with a 25% dividend increase	Feb. 29
Berenberg Starts Wendel Coverage with Buy Rating	Feb. 15	MT
WENDEL : Berenberg initiates coverage with a buy recommendation	Feb. 15	CF
WENDEL : Q3 23: new strategic axes kick into high gear	23-10-27
WENDEL : Half-hearted Q3-23 results	23-10-27
WENDEL : Builds up its third-party asset management arm	23-10-17
WENDEL : Wendel has lost its appeal	23-10-16
WENDEL : Sluggish H1 results, albeit active portfolio rotation	23-07-28
WENDEL : In the midst of portfolio rotation	23-07-27
WENDEL : EPS cut (2022: -69.0%, 2023: +25.2%)	23-06-16
WENDEL : Q1 23: Wendel doubles down on its ambitions	23-04-28
Moody's Affirms Wendel Ratings on New Strategic Direction	23-03-29	MT
WENDEL : The up-and-coming alternative asset manager ?	23-03-17
WENDEL : Which path will Wendel take?	22-12-02
WENDEL : A discount to grab	22-10-28
Wendel : Stahl underlines responsible supply chain commitment with EcoVadis Platinum rating	22-09-19	PU
WENDEL : 2022 off to promising start	22-08-01
WENDEL : What’s next for Wendel ?	22-06-24
WENDEL : NAV in decline despite solid top-line progression for the portfolio companies	22-04-28
WENDEL : FY21: an upbeat performance at odds with widening discount to NAV	22-03-18
Sutro Early-Stage Ovarian Cancer Study Shows 33% Objective Response Rate -- Shares Drop in Pre-Market Trading	22-01-06	MT